Chronicle Journal: Finance

Spark enters gene therapy discovery deal that could exceed $645M

The companies are seeking to develop 'next-generation' gene therapies directed at specific cell types in the central nervous system, eye or liver.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.